As physicians within Biopharma and Medical Affairs (MA) teams are increasingly expected to navigate a far more complex healthcare universe, the most forward-thinking companies focus on being masters of data and digital technologies and whilst focusing on exceling in this area are expected to communicate the scientific evidence in a far more effective and outcome
A recent review has stated that there needs to be easier access to NHS screening programmes in England, including evening and weekend clinics in order to increase uptake. The report by Prof Sir Mike Richards also called for tests to be offered in a wider variety of locations, including mobile units and recommended using social
NHS has announced a new whistle-blower scheme, which is set to roll out across the country for staff who raise the alarm on unsafe practice. The launch of the career support scheme follows two pilot projects started in 2017 which offered targeted support to 16 people who left the health service after they raised concerns
Experts have stated that Olaparib could become a revolutionary treatment for prostate cancer – the first genetically targeted drug for fighting the disease. The precision medicine is already used by the NHS for ovarian cancer and has been called a game-changer by cancer doctors. Findings presented at a recent conference show how in trials, it
According to a recent study published in Cardiovascular Research, a journal of the European Society of Cardiology (ESC), people with gum disease (periodontitis) are more likely to have high blood pressure (hypertension). Senior author Professor Francesco D’Aiuto of UCL Eastman Dental Institute, UK, said: “We observed a linear association – the more severe periodontitis is, the
The Association of the British Pharmaceutical Industry (ABPI) and Birmingham Health Partners (BHP) have formed a partnership in order to “tackle the biggest health challenges” within Birmingham. The partnership, which will focus on West Midlands’ six million residents, will utilise real-time clinical trials and health data to accelerate research and improve cancer care, maternity services,
In a new study undertaken in the early stage of prostate cancer, Angle report that their test, Parsortix has demonstrated the potential to out-perform current standard of care with regards detection and assessment of the disease. To date, investigation of symptoms for prostate cancer are typically made via a blood test measuring prostate specific antigen
According to new research conducted by University of St Andrews announced that women are risking their lives by not taking part in bowel screening tests. The research team found that while 81% of women took part in cervical cancer screening and 73% in breast cancer screening, only 60% of women took part in bowel screening.
NHS England has made Roche’s emicizumab (also referred to as Hemlibra®) available on NHS and is set to fund the “life-changing treatment” for thousands of people with severe Haemophilia. A move which is said to dramatically cut patient’s risk of life-threatening bleeds and reduce treatment time. The new treatment is part of a package of
Gedeon Richter has announced that their biosimilar for osteoporosis, Teriparatide, is to be made available on the NHS for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. As a result, the NHS can now provide an additional option for the treatment of osteoporosis in this subset of patients.